Compare Incyte Corporation (INCY) vs Xylem, Inc. (XYL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Incyte Corporation vs Xylem, Inc. — how do they compare? Incyte Corporation trades at $115.7 (market cap $23.11B), while Xylem, Inc. trades at $120.79 (market cap $28.67B). The key difference: Xylem, Inc. is the larger of the two by market cap, and Xylem, Inc. pays a 1.43% dividend while Incyte Corporation pays none. Which is the better fit depends on your goals.
| INCY | XYL | |
|---|---|---|
Market Cap | $23.11B | $28.67B |
Sector | Health | Industrials |
52-Week High | $118.52 | $152.95 |
52-Week Low | $67.38 | $106.34 |
Enterprise Value | $19.13B | $29.92B |
Dividend Yield | — | 1.43% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Incyte Corporation
Incyte focuses on the discovery and development of small-molecule drugs. The firm's lead drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis. Incyte's pipeline includes a broad array of oncology and dermatology programs.
Read more on INCY →About Xylem, Inc.
Xylem is a global leader in water technology and offers a wide range of solutions, including the transport, treatment, testing, and efficient use of water for customers in the utility, industrial, commercial, and residential sectors. Xylem was spun off from ITT in 2011. Based in Rye Brook, New York, Xylem has a presence in over 150 countries and employs 16,200. The company generated $6.2 billion in revenue and $611 million in adjusted operating income in 2021.
Read more on XYL →
